MLX0487-23

N/A

Report date: 2025/08/21 17:58:01

Base Information

Drug NameMLX0487-23

Drug Alias NameMLX0487-23

ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccineCell and gene therapy > Gene therapy > LNP

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsPapillomavirus Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesMETiS Pharmaceuticals

China Registration ClassN/A

Develop Information

Active CompaniesMETiS Pharmaceuticals

Inactive CompaniesN/A

Active IndicationsPapillomavirus Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A